Infliximab induces remission of pyoderma gangrenosum.

Detalles Bibliográficos
Publicado en:European Journal of Gastroenterology & Hepatology Vol. 14; no. 8; pp. 907 - 908
Autores principales: Romero-Gómez, Manuel, Sánchez-Muñoz, Diego
Formato: letter Journal Article
Publicado: Lippincott Williams & Wilkins 2002 Aug
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138562627&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 138562627
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0954691X
        8CE
      jtl: European Journal of Gastroenterology & Hepatology
      issn: 0954691X
      maglogo: N
    pubinfo:
      dt: 2002 Aug
      vid: 14
      iid: 8
      pid: 5086
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        138562627
        138562627
        NLM12172418
        138562627
        10.1097/00042737-200208000-00021
        NLM12172418
        138562627
      ppf: 907
      ppct: 1
      formats:
      tig:
        atl: Infliximab induces remission of pyoderma gangrenosum.
      aug:
        au:
          Romero-Gómez, Manuel
          Sánchez-Muñoz, Diego
      sug:
        subj:
          Antibodies, Monoclonal Administration and Dosage
          Pyoderma Gangrenosum Drug Therapy
          Fissure in Ano Drug Therapy
          Female
          Fissure in Ano Diagnosis
          Adult
          Fissure in Ano Complications
          Prospective Studies
          Pyoderma Gangrenosum Diagnosis
          Pyoderma Gangrenosum Complications
          Treatment Outcomes
          Infusions, Intravenous
          Adult: 19-44 years
          Female
      pubtype: Academic Journal
      doctype:
        letter
        Journal Article
      ougenre: Unknown
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N